At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
3D Imagingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery: Does 3D Improve Patient Reported Outcomes in Primary Breast Augmentation?
In Brief
A clinical study evaluating 3D Imaging for Hypomastia and Primary Breast Augmentation. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The purpose of this trial is to evaluate the impact of incorporating three-dimensional (3D)imaging during preoperative consultation on patient reported outcomes in primary breast augmentation surgery. 3D imaging is an innovative technology that allows the surgeon to share with images how one could look after one's procedure. The patient's assessment will be collected using the Breast Q, an objective questionnaire that captures patient satisfaction with breast augmentation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypomastia, Primary Breast Augmentation
CountriesUnited States
CollaboratorsAllergan
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
First PostedOct 2013
Primary CompletionMay 2017
TodayJul 2026
First PostedOct 17, 2013
Enrollment StartNov 1, 2012
Primary CompletionMay 16, 2017
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 12.7 years ago
Interventions
3D Imagingdevice